Munich, May 28, 2021 – The shareholders LIVIA Corporate Development SE and HDI Vier CE GmbH sold approximately 1.5 million shares (approximately 15% of the share capital) to institutional investors via a private placement. With this placement, the selling shareholders are pursuing the goal of increasing the free float and thus the liquidity of AlzChem Group AG shares. More details about the investors point of view concerning the company’s development are given by Prof. Dr. Dr. Peter Löw and Dr. Martin Vorderwülbecke in the interview below.
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.